168 tracked 13F filers disclose a position in CGEM as of the latest SEC 13F filings, a combined $1.0B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | $163.2M | 9.0M | —Held | Q2 2026 | |
| 2 | MPM BioImpact LLC | $108.7M | 7.6M | —Held | Q1 2026 | |
| 3 | BVF INC/IL | $81.7M | 5.8M | —Held | Q1 2026 | |
| 4 | BlackRock, Inc. | $63.2M | 4.4M | ▲+1.1% Added · +50K sh | Q1 2026 | |
| 5 | STATE STREET CORP | $66.8M | 3.7M | ▲+44% Added · +1.1M sh | Q2 2026 | |
| 6 | Kynam Capital Management, LP | $44.3M | 3.1M | —Held | Q1 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $35.3M | 2.5M | →First observed position No prior filed position | Q1 2026 | |
| 8 | RTW INVESTMENTS, LP | $43.1M | 2.4M | ▲+39% Added · +658K sh | Q2 2026 | |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | $28.8M | 2.0M | ▲43× Added · +2.0M sh | Q1 2026 | |
| 10 | Siren, L.L.C. | $34.5M | 1.9M | ▲+59% Added · +700K sh | Q2 2026 | |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | $28.2M | 1.5M | ▲+13% Added · +179K sh | Q2 2026 | |
| 12 | Blue Owl Capital Holdings LP | $28.0M | 1.5M | ▼−19% Reduced · −370K sh | Q2 2026 | |
| 13 | Venrock Adviser, LLC | $19.6M | 1.4M | —Held | Q1 2026 | |
| 14 | Nextech Invest Ltd. | $16.2M | 1.1M | —Held | Q1 2026 | |
| 15 | BOOTHBAY FUND MANAGEMENT, LLC | $15.8M | 1.1M | ▼−10% Reduced · −124K sh | Q1 2026 | |
| 16 | MARSHALL WACE, LLP | $14.9M | 1.0M | ▲+153% Added · +635K sh | Q1 2026 | |
| 17 | DIMENSIONAL FUND ADVISORS LP | $12.9M | 906K | ▲+6.7% Added · +57K sh | Q1 2026 | |
| 18 | Nuveen, LLC | $11.4M | 806K | ▲+39% Added · +227K sh | Q1 2026 | |
| 19 | Affinity Asset Advisors, LLC | $11.1M | 781K | ▼−60% Reduced · −1.2M sh | Q1 2026 | |
| 20 | TWIN FOCUS CAPITAL PARTNERS, LLC | $10.8M | 595K | —Held | Q2 2026 | |
| 21 | MORGAN STANLEY | $8.4M | 589K | ▼−23% Reduced · −177K sh | Q1 2026 | |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLC | $7.9M | 553K | →First observed position No prior filed position | Q1 2026 | |
| 23 | TWO SIGMA INVESTMENTS, LP | $7.4M | 522K | ▲+11% Added · +52K sh | Q1 2026 | |
| 24 | BANK OF AMERICA CORP /DE/ | $7.3M | 517K | ▲+49% Added · +170K sh | Q1 2026 | |
| 25 | GOLDMAN SACHS GROUP INC | $6.5M | 455K | ▼−37% Reduced · −266K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 7 funds opened a new position in CGEM and 22 added to an existing one, while 18 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 73 funds | $227.5B |
| AMAZON.COM INCAMZN | 72 funds | $104.6B |
| ELI LILLY & COLLY | 72 funds | $44.8B |
| BOSTON SCIENTIFIC CORPBSX | 72 funds | $7.7B |
| MICROSOFT CORPMSFT | 70 funds | $148.9B |
| BROADCOM INCAVGO | 70 funds | $89.4B |
| VERTEX PHARMACEUTICALS INCVRTX | 70 funds | $7.7B |
| CAPITAL ONE FINANCIAL CORPCOF | 70 funds | $6.7B |
| CENTENE CORPCNC | 70 funds | $3.0B |
| ALPHABET INC-CL AGOOGL | 69 funds | $83.1B |
| META PLATFORMS INC-CLASS AMETA | 69 funds | $64.8B |
| MICRON TECHNOLOGY INCMU | 69 funds | $20.9B |
Ranked by how many of CGEM's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 30K | $608K |
| Jul 6, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 8K | $143K |
| May 5, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 8K | $114K |
| May 5, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 200 | $3K |
| Mar 5, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 8K | $125K |
| Feb 25, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 2K | $25K |
| Feb 24, 2026 | SUMER JACQUELYN L | Chief Legal Officer | Sell (S) | 4K | $52K |
| Feb 24, 2026 | Jones Jeffrey Alan | Chief Medical Officer | Sell (S) | 5K | $66K |
| Feb 24, 2026 | AHMED NADIM | President and CEO, Director | Sell (S) | 14K | $196K |
| Feb 24, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 4K | $52K |
| Feb 23, 2026 | Michaelson Jennifer | Chief Scientific Officer | Sell (S) | 2K | $25K |
| Feb 20, 2026 | AHMED NADIM | President and CEO, Director | Sell (S) | 16K | $223K |
Connected entities for CGEM
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CGEM/capital-change-brief"
Use Arkolith's capital_change_brief for CGEM. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CGEM. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.